GeneDx Holdings Corp. Cash Flow Statement

Cash Flow Statement Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -29.70M-241.34M-245.39M-548.93M-175.77M-52.29M
Depreciation and Depletion 11.73M21.81M49.96M19.71M7.93M
Share-based Compensation 5.48M120.23M219.42M41.98M-0.33M9.14M
Deferred Taxes -49.12M-0.93M-0.34M
Gains from Investment Securities 4.01M-198.40M-70.23M3.60M13.37M
Asset Writedowns and Impairment 2.13M210.15M10.40M0.18M
Cash from Operations -18.73M-93.13M-190.43M-319.15M-180.15M-28.50M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges 0.07M0.52M
Depreciation & Amortization (CF) 6.41M11.73M21.81M59.31M33.73M21.95M
Change in Working Capital
Change in Receivables 4.57M10.61M-5.54M-5.53M-10.26M5.42M
Change in Inventory 7.97M8.98M10.62M-2.35M-0.97M2.58M
Change in Accured Expenses 12.85M15.96M25.92M34.46M-46.95M-20.46M
Other Working Capital Changes 4.39M-2.50M14.25M8.46M2.53M-3.72M
Investing Activities
Capital Expenditures 11.92M24.09M11.39M7.17M5.25M5.49M
Sales of Property, Plant and Equipment 4.03M
Acquisitions 127.00M12.14M
Change in Acquisitions & Divestments 17.77M41.06M
Cash from Investing Activities -15.46M-31.97M-20.79M-141.33M-43.73M-30.13M
Financing Activities
Other financing activities 0.54M
Cash from Financing Activities 148.01M129.06M493.73M197.31M186.24M44.16M
Additional items
Change in Cash 113.83M3.95M282.51M-263.17M-37.63M-14.47M
Free Cash Flow -30.65M-117.22M-201.82M-326.32M-185.40M-33.99M
Net Cash Flow 113.83M3.95M282.51M-263.17M-37.63M-14.47M